Compile Data Set for Download or QSAR
maximum 50k data
Found 3206 with Last Name = 'stockley' and Initial = 'm'
TargetDNA-dependent protein kinase catalytic subunit(Homo sapiens (Human))
School Of Natural Sciences--Chemistry

Curated by ChEMBL
LigandPNGBDBM50156495(8-(dibenzo[b,d]thiophen-4-yl)-2-morpholino-4H-chro...)
Affinity DataKi:  0.650nMAssay Description:Inhibitory activity against DNA-dependent protein kinase receptorMore data for this Ligand-Target Pair
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50091438((E)-3-(3,4-Dichloro-phenyl)-N-{5-[4-(5-hydroxy-1H-...)
Affinity DataKi:  50nMAssay Description:Antagonist activity against C-C chemokine receptor type 2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50091449((E)-3-(3,4-Dichloro-phenyl)-N-{5-[4-(5-methanesulf...)
Affinity DataKi:  79nMAssay Description:Antagonist activity against C-C chemokine receptor type 2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetDNA-dependent protein kinase catalytic subunit(Homo sapiens (Human))
School Of Natural Sciences--Chemistry

Curated by ChEMBL
LigandPNGBDBM15234((1R,3R,5S,9R,18S)-18-(methoxymethyl)-1,5-dimethyl-...)
Affinity DataKi:  120nMAssay Description:Binding affinity for DNA dependent protein kinase isolated from HeLa cells; Range is 20-120More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Newcastle University

Curated by ChEMBL
LigandPNGBDBM15234((1R,3R,5S,9R,18S)-18-(methoxymethyl)-1,5-dimethyl-...)
Affinity DataKi:  120nMAssay Description:Inhibition of human recombinant p110 alpha Phosphatidylinositol 3-kinaseMore data for this Ligand-Target Pair
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50091457((E)-3-(3,4-Dichloro-phenyl)-N-{5-[4-(5-hydroxy-2-m...)
Affinity DataKi:  234nMAssay Description:Antagonist activity against C-C chemokine receptor type 2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50091454((E)-3-(4-Bromo-phenyl)-N-{5-[4-(1H-indol-3-yl)-pip...)
Affinity DataKi:  350nMAssay Description:Antagonist activity against C-C chemokine receptor type 2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50091461((E)-3-(3,4-Dichloro-phenyl)-N-{5-[4-(4-hydroxy-1H-...)
Affinity DataKi:  360nMAssay Description:Antagonist activity against C-C chemokine receptor type 2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50091451((E)-3-(3,4-Dichloro-phenyl)-N-{5-[4-(6-hydroxy-1H-...)
Affinity DataKi:  360nMAssay Description:Antagonist activity against C-C chemokine receptor type 2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50091458((E)-3-(3,4-Dichloro-phenyl)-N-{5-[4-(1H-indol-3-yl...)
Affinity DataKi:  420nMAssay Description:Antagonist activity against C-C chemokine receptor type 2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50091465((E)-N-(5-(4-(1H-indol-3-yl)piperidin-1-yl)pentyl)-...)
Affinity DataKi:  460nMAssay Description:Antagonist activity against C-C chemokine receptor type 2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50091445((E)-3-(4-Chloro-phenyl)-N-{5-[4-(1H-indol-3-yl)-pi...)
Affinity DataKi:  520nMAssay Description:Antagonist activity against C-C chemokine receptor type 2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50091471((E)-N-(5-(4-(1H-indol-3-yl)piperidin-1-yl)pentyl)-...)
Affinity DataKi:  550nMAssay Description:Antagonist activity against C-C chemokine receptor type 2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50091460((E)-3-(3-Chloro-phenyl)-N-{5-[4-(1H-indol-3-yl)-pi...)
Affinity DataKi:  560nMAssay Description:Antagonist activity against C-C chemokine receptor type 2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50091470((E)-3-(3,4-Dichloro-phenyl)-N-{5-[4-(5-methoxy-1H-...)
Affinity DataKi:  590nMAssay Description:Antagonist activity against C-C chemokine receptor type 2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50091442((E)-3-(3,4-Dichloro-phenyl)-N-{4-[4-(1H-indol-3-yl...)
Affinity DataKi:  660nMAssay Description:Antagonist activity against C-C chemokine receptor type 2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50091467((E)-N-(5-(4-(1H-indol-3-yl)piperidin-1-yl)pentyl)-...)
Affinity DataKi:  790nMAssay Description:Antagonist activity against C-C chemokine receptor type 2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50091448((E)-N-(5-(4-(1H-indol-3-yl)piperidin-1-yl)pentyl)-...)
Affinity DataKi:  790nMAssay Description:Antagonist activity against C-C chemokine receptor type 2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50091439((E)-N-(5-(4-(1H-indol-3-yl)piperidin-1-yl)pentyl)c...)
Affinity DataKi:  870nMAssay Description:Antagonist activity against C-C chemokine receptor type 2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50091468((E)-3-(4-Dimethylamino-phenyl)-N-{5-[4-(1H-indol-3...)
Affinity DataKi:  1.20E+3nMAssay Description:Antagonist activity against C-C chemokine receptor type 2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50091443((E)-3-Biphenyl-4-yl-N-{5-[4-(1H-indol-3-yl)-piperi...)
Affinity DataKi:  1.45E+3nMAssay Description:Antagonist activity against C-C chemokine receptor type 2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50091441(1-(3,4-Dichloro-phenyl)-3-{5-[4-(1H-indol-3-yl)-pi...)
Affinity DataKi:  1.60E+3nMAssay Description:Antagonist activity against C-C chemokine receptor type 2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50091447((E)-3-(4-tert-Butyl-phenyl)-N-{5-[4-(1H-indol-3-yl...)
Affinity DataKi:  1.70E+3nMAssay Description:Antagonist activity against C-C chemokine receptor type 2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50091453((E)-3-(3,4-Dichloro-phenyl)-N-{3-[4-(1H-indol-3-yl...)
Affinity DataKi:  2.50E+3nMAssay Description:Antagonist activity against C-C chemokine receptor type 2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50091446((E)-3-(4-Cyano-phenyl)-N-{5-[4-(1H-indol-3-yl)-pip...)
Affinity DataKi:  2.80E+3nMAssay Description:Antagonist activity against C-C chemokine receptor type 2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50091452((E)-3-(4-Acetylamino-phenyl)-N-{5-[4-(1H-indol-3-y...)
Affinity DataKi:  2.90E+3nMAssay Description:Antagonist activity against C-C chemokine receptor type 2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50091456((E)-3-(3,4-Dichloro-phenyl)-N-{5-[4-(5-hydroxy-1-m...)
Affinity DataKi:  4.20E+3nMAssay Description:Antagonist activity against C-C chemokine receptor type 2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetC-C chemokine receptor type 5(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50091438((E)-3-(3,4-Dichloro-phenyl)-N-{5-[4-(5-hydroxy-1H-...)
Affinity DataKi:  4.26E+3nMAssay Description:Compound was evaluated for the antagonist activity against C-C chemokine receptor type 5More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50091466((E)-3-(2-Chloro-phenyl)-N-{5-[4-(1H-indol-3-yl)-pi...)
Affinity DataKi:  4.40E+3nMAssay Description:Antagonist activity against C-C chemokine receptor type 2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50091464(2-(3,4-Dichloro-phenyl)-N-{5-[4-(1H-indol-3-yl)-pi...)
Affinity DataKi:  4.40E+3nMAssay Description:Antagonist activity against C-C chemokine receptor type 2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50091459(3,4-Dichloro-N-{5-[4-(1H-indol-3-yl)-piperidin-1-y...)
Affinity DataKi:  5.10E+3nMAssay Description:Antagonist activity against C-C chemokine receptor type 2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50091444(Biphenyl-4-carboxylic acid {5-[4-(1H-indol-3-yl)-p...)
Affinity DataKi:  5.30E+3nMAssay Description:Compound was evaluated for the antagonist activity against human C-C chemokine receptor type 2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50091444(Biphenyl-4-carboxylic acid {5-[4-(1H-indol-3-yl)-p...)
Affinity DataKi:  5.40E+3nMAssay Description:Antagonist activity against C-C chemokine receptor type 2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50091450(3-(3,4-Dichloro-phenyl)-N-{5-[4-(1H-indol-3-yl)-pi...)
Affinity DataKi:  5.90E+3nMAssay Description:Antagonist activity against C-C chemokine receptor type 2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Newcastle University

Curated by ChEMBL
LigandPNGBDBM12915(2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one |...)
Affinity DataKi:  6.00E+3nMAssay Description:Binding affinity for Phosphatidylinositol-3-kinase isolated from HeLa cells; Range is 20-120More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50091455((E)-3-(4-Hydroxy-phenyl)-N-{5-[4-(1H-indol-3-yl)-p...)
Affinity DataKi:  6.30E+3nMAssay Description:Antagonist activity against C-C chemokine receptor type 2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50091472(4-Bromo-N-{5-[4-(1H-indol-3-yl)-piperidin-1-yl]-pe...)
Affinity DataKi:  7.10E+3nMAssay Description:Antagonist activity against C-C chemokine receptor type 2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50091463(3,4-Dichloro-N-{5-[4-(1H-indol-3-yl)-piperidin-1-y...)
Affinity DataKi: >1.00E+4nMAssay Description:Antagonist activity against C-C chemokine receptor type 2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50091469(Biphenyl-4-carboxylic acid {6-[4-(1H-indol-3-yl)-p...)
Affinity DataKi: >1.00E+4nMAssay Description:Antagonist activity against C-C chemokine receptor type 2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetC-C chemokine receptor type 2(Homo sapiens (Human))
Smithkline Beecham Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50091462((E)-3-(3,4-Dichloro-phenyl)-N-{2-[4-(1H-indol-3-yl...)
Affinity DataKi: >1.00E+4nMAssay Description:Antagonist activity against C-C chemokine receptor type 2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUbiquitin carboxyl-terminal hydrolase 30(Homo sapiens (Human))
Mission Therapeutics

US Patent
LigandPNGBDBM513567((R)-3-(5-(2′-methoxy-[1,1′-biphenyl]-3...)
Affinity DataIC50: <0.100nMAssay Description:Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin carboxyl-terminal hydrolase 30(Homo sapiens (Human))
Mission Therapeutics

US Patent
LigandPNGBDBM513564(3-(5-(4-methyl-3-oxo-3,4-dihydro-2H-benzo[b][1,4]o...)
Affinity DataIC50: <0.100nMAssay Description:Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin carboxyl-terminal hydrolase 30(Homo sapiens (Human))
Mission Therapeutics

US Patent
LigandPNGBDBM513570((R)-3-(5-([1,1'-biphenyl]-3-yl)-1,1- dioxido-1,2,5...)
Affinity DataIC50: <0.100nMAssay Description:Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin carboxyl-terminal hydrolase 30(Homo sapiens (Human))
Mission Therapeutics

US Patent
LigandPNGBDBM513572((R)-3-(5-(4-methoxy-[1,1'- biphenyl]-3-yl)-1,1-dio...)
Affinity DataIC50: <0.100nMAssay Description:Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin carboxyl-terminal hydrolase 30(Homo sapiens (Human))
Mission Therapeutics

US Patent
LigandPNGBDBM513574((R)-3-(5-(3'-methoxy-[1,1'- biphenyl]-3-yl)-1,1-di...)
Affinity DataIC50: <0.100nMAssay Description:Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin carboxyl-terminal hydrolase 30(Homo sapiens (Human))
Mission Therapeutics

US Patent
LigandPNGBDBM513575((R)-3-(5-(2'-methoxy-[1,1'- biphenyl]-4-yl)-1,1-di...)
Affinity DataIC50: <0.100nMAssay Description:Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin carboxyl-terminal hydrolase 30(Homo sapiens (Human))
Mission Therapeutics

US Patent
LigandPNGBDBM513576((R)-3-(1,1-dioxido-5-(4-(pyridin-4- yl)phenyl)-1,2...)
Affinity DataIC50: <0.100nMAssay Description:Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin carboxyl-terminal hydrolase 30(Homo sapiens (Human))
Mission Therapeutics

US Patent
LigandPNGBDBM513577((R)-3-(1,1-dioxido-5-(3-(pyridin-4- yl)phenyl)-1,2...)
Affinity DataIC50: <0.100nMAssay Description:Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin carboxyl-terminal hydrolase 30(Homo sapiens (Human))
Mission Therapeutics

US Patent
LigandPNGBDBM513578((R)-3-(5-(3-(1-methyl-1H-pyrazol- 4-yl)phenyl)-1,1...)
Affinity DataIC50: <0.100nMAssay Description:Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetUbiquitin carboxyl-terminal hydrolase 30(Homo sapiens (Human))
Mission Therapeutics

US Patent
LigandPNGBDBM513568((R)-3-(5-([1,1'-biphenyl]-4-yl)-1,1- dioxido-1,2,5...)
Affinity DataIC50: <0.100nMAssay Description:Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 3206 total ) | Next | Last >>
Jump to: